产品名称：Human LAG3 / CD223 Antibody (Favezelimab, Research Use)
产品编号：NBR-0788
针对靶点：LAG3 / CD223
抗体药商品名：Favezelimab
抗体药描述：Favezelimab is an ongoing LAG-3 antibody developed by Merck, which can block the interaction between MHCII receptors and LAG-3, inhibit the up-regulation of LAG-3, and then restore the killing effect of T cells on tumor cells. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: LAG3
Synonyms: CD223
Target Description: Lymphocyte activation gene 3 protein: Inhibitory receptor on antigen activated T-cells. Delivers inhibitory signals upon binding to ligands, such as FGL1 (By similarity).
Ensembl:  ENSG00000089692
Uniprot: P18627